Vascular interventional therapy for hepatocellular carcinoma (HCC) is the most important treatment modality for unresectable HCC, including transcatheter arterial chemoembolization and hepatic arterial infusion chemotherapy. With the development and application of new materials and surgical procedures, the above treatment regimens have been modified and optimized, and various clinical studies have discussed the clinical effect of different regimens in the treatment of HCC and have made new achievements, which provides new strategies and a theoretical basis for vascular interventional therapy for HCC in clinical practice. This article summarizes the new advances in the clinical research on vascular interventional therapy for HCC
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related deaths worldwide, espe...
Background: To improve the survival rate of patients with hepatocellular carcinoma (HCC) in whom sur...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
Copyright © 2014 Ming-Chun Ma et al.This is an open access article distributed under the Creative Co...
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treat...
Recent advance of the treatment of hepatocellular carcinoma utilizing lipiodol containing anti-cance...
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treat...
Hepatocellular carcinoma (HCC) is the fifth most frequently found primary malignant tumor in the worl...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer...
Hepatocellular carcinoma (HCC) consists of heterogeneous tumors regarding morphology, biology, and u...
Technical innovation and development of devices and imaging machine have brought recent advances of ...
WOS: 000377556100001PubMed ID: 27298100BACKGROUND: Hepatocellular carcinoma (Hcc.), is, a complex an...
Hepatocellular carcinoma (HCC) is an epithelial tumor derived from hepatocytes; it accounts for 80% ...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related deaths worldwide, espe...
Background: To improve the survival rate of patients with hepatocellular carcinoma (HCC) in whom sur...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) is one of the most refractory malignancies worldwide, and there are a...
Copyright © 2014 Ming-Chun Ma et al.This is an open access article distributed under the Creative Co...
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treat...
Recent advance of the treatment of hepatocellular carcinoma utilizing lipiodol containing anti-cance...
Management of hepatocellular carcinoma (HCC) can be maximized with the utilization of multiple treat...
Hepatocellular carcinoma (HCC) is the fifth most frequently found primary malignant tumor in the worl...
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer...
Hepatocellular carcinoma (HCC) consists of heterogeneous tumors regarding morphology, biology, and u...
Technical innovation and development of devices and imaging machine have brought recent advances of ...
WOS: 000377556100001PubMed ID: 27298100BACKGROUND: Hepatocellular carcinoma (Hcc.), is, a complex an...
Hepatocellular carcinoma (HCC) is an epithelial tumor derived from hepatocytes; it accounts for 80% ...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related deaths worldwide, espe...
Background: To improve the survival rate of patients with hepatocellular carcinoma (HCC) in whom sur...
Hepatocellular carcinoma (HCC) represents one of the few cancers for which locoregional treatments a...